Verified
Nova Biomedical GmbH
About Nova Biomedical
Nova Biomedical develops, manufactures and commercializes analyzer for cell culture & chemistry and whole blood testing. Company headquarters are located in Waltham, MA, USA. Nova employs over 1,300 employees worldwide. Nova Biomedical has a 40-year history as the world leader in developing whole blood biosensors for clinical and cell culture/fermentation use. Nova’s BioProfile® FLEX2 is the latest addition to the BioProfile line of automated cell culture analyzers. It combines groundbreaking sensor card technology with optical cell imaging technology and freezing point osmometry. FLEX2 is available with an optional on-line autosampler, allwoing for a fully automated sampling and analysis for up to 10 bioreactors.
- Focus : Manufacturer
- Employees: 1001-5,000
- Industry : Biotechnology, Diagnostics
Product portfolio of Nova Biomedical
Here you will find Nova Biomedical GmbH
See the theme worlds for related content
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
Topic world Cell culture technology
Cell culture technology is a central pillar in biotechnological and pharmaceutical research and development. It enables the growth and maintenance of cells under controlled laboratory conditions, providing a window into the molecular and cellular processes of life.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.